Company intelligence / Profile preview
Shanghai Sine
- Ownership
- Private
- Employees
- ~5000
- Development stage
- Other
Overview
Shanghai Sine is a prominent Chinese pharmaceutical company and a core subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd. Founded in 1916, it is one of the oldest and most established pharmaceutical manufacturers in China, specializing in a wide range of therapeutic areas including cardiovascular, gastrointestinal, and respiratory health. The company is particularly well-known for its leadership in the probiotics market, notably with its Bifidobacterium preparations such as Bifidobi. Shanghai Sine operates multiple manufacturing bases and R&D centers, focusing on the production of high-quality generic drugs and innovative formulations. Its extensive product portfolio and long-standing brand reputation make it a key player in the Chinese domestic healthcare market.
- Therapeutic areas
- EndocrinologyCardiovascularInfectious DiseasesPulmonologyGastroenterology
- Modalities
- Small moleculeLive biotherapeutic product therapyBiologic
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Shanghai Sine.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai Sine.